Last reviewed · How we verify

NCT05233319

mCVI Confirmatory Clinical Study: Algorithm Verification With Healthy Volunteers

Withdrawn Last updated 14 February 2023
What this trial tests

trial testing There is no intervention in Algorithm Verification. Withdrawn.

Timeline
31 December 2022
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorIntelomed, Inc.
StatusWithdrawn
Study typeOBSERVATIONAL
Start date31 December 2022
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Intelomed, Inc.

Who can join

Adults 21 to 70, any sex, with Algorithm Verification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This single center confirmatory clinical study is to verify the algorithm of mCVI® to accurately capture pulse rate and respiratory rate in 20 healthy subjects in comparison to traditional measurements of the Nonin Lifesense Capnograph. This is a non significant risk device.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of There is no intervention

Trials testing the same drug.

Other Intelomed, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05233319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing